- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 261/04 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Patent holdings for IPC class C07D 261/04
Total number of patents in this class: 479
10-year publication summary
|
25
|
27
|
29
|
47
|
37
|
36
|
26
|
24
|
24
|
38
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer AG | 3563 |
39 |
| Corteva Agriscience LLC | 2648 |
28 |
| Syngenta Crop Protection AG | 6789 |
22 |
| Syngenta Participations AG | 1476 |
19 |
| Nissan Chemical Industries, Ltd. | 1629 |
19 |
| BASF SE | 21318 |
17 |
| Bayer Cropscience AG | 1821 |
15 |
| Boehringer Ingelheim Animal Health USA Inc. | 415 |
14 |
| Sumitomo Chemical Company, Limited | 8989 |
13 |
| Intervet Inc. | 947 |
11 |
| Qingdao Kingagroot Chemical Compound Co., Ltd. | 241 |
11 |
| Intervet International B.V. | 1342 |
9 |
| Kumiai Chemical Industry Co., Ltd. | 314 |
8 |
| FMC Corporation | 815 |
7 |
| OP Bio Factory Co., Ltd. | 14 |
7 |
| Seed Research Institute Co., Ltd. | 12 |
7 |
| Theravance Biopharma R&D IP, LLC | 358 |
7 |
| E. I. du Pont de Nemours and Company | 3452 |
6 |
| Centrexion Therapeutics Corporation | 65 |
6 |
| Korea Research Institute of Chemical Technology | 1492 |
6 |
| Other owners | 208 |